Once a risky investment, the psychedelic medicine industry now provides a promising opportunity for psychedelic investors to benefit and help in delivering better treatment outcomes for people suffering. Psychedelic drugs such as psilocybin and MDMA are showing encouraging results in treating mental health diagnoses such as depression, eating disorders, and addiction. Psychedelic medicine stocks are […]